Activation of the alternative complement pathway.
作者信息
Fearon D T
出版信息
CRC Crit Rev Immunol. 1979 Nov;1(1):1-32.
PMID:162484
Abstract
摘要
相似文献
1
Activation of the alternative complement pathway.替代补体途径的激活。
CRC Crit Rev Immunol. 1979 Nov;1(1):1-32.
2
The alternative pathway of complement.补体替代途径
Springer Semin Immunopathol. 1984;7(2-3):163-92. doi: 10.1007/BF01893019.
3
Molecular biology and chemistry of the alternative pathway of complement.补体替代途径的分子生物学与化学
Adv Immunol. 1980;29:1-53. doi: 10.1016/s0065-2776(08)60042-5.
4
[Alternative complement pathway].[替代补体途径]
Sem Hop. 1984 May 3;60(19):1371-8.
5
The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.人补体蛋白C5、B因子、β1H和备解素与酵母聚糖上的补体片段C3b的结合。
Biochem J. 1981 Dec 1;199(3):485-96. doi: 10.1042/bj1990485.
6
A circulating inhibitor of fluid-phase amplification. C3 convertase formation in systemic lupus erythematosus.液相放大的循环抑制剂。系统性红斑狼疮中C3转化酶的形成。
J Clin Invest. 1985 Jun;75(6):1786-95. doi: 10.1172/JCI111891.
7
[The alternative complement pathway].[替代补体途径]
Pathol Biol (Paris). 1983 Dec;31(10):839-46.
8
Autoantibodies Against C3b-Functional Consequences and Disease Relevance.针对 C3b 功能后果的自身抗体及其与疾病的相关性。
Front Immunol. 2019 Jan 29;10:64. doi: 10.3389/fimmu.2019.00064. eCollection 2019.
9
The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?备解素途径：C3 和 C5 激活的“替代激活途径”还是“关键扩增环”？
Semin Immunopathol. 2018 Jan;40(1):15-35. doi: 10.1007/s00281-017-0661-x. Epub 2017 Nov 22.
10
Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.由肾炎因子稳定的经典和替代补体途径C3转化酶免受人类C3b受体介导的衰变作用。
Eur J Immunol. 1984 Dec;14(12):1111-4. doi: 10.1002/eji.1830141209.
引用本文的文献
1
Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).抗磷脂抗体阳性患者的抗磷脂综合征（APS）与系统性红斑狼疮（SLE）中补体的相反特征。
Front Immunol. 2019 May 7;10:885. doi: 10.3389/fimmu.2019.00885. eCollection 2019.
2
The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?备解素途径：C3 和 C5 激活的“替代激活途径”还是“关键扩增环”？
Semin Immunopathol. 2018 Jan;40(1):15-35. doi: 10.1007/s00281-017-0661-x. Epub 2017 Nov 22.
3
Comparative analysis of serum proteome in congenital scoliosis patients with TBX6 haploinsufficiency - a first report pointing to lipid metabolism.先天性脊柱侧凸伴 TBX6 杂合不足患者血清蛋白质组的比较分析 - 首次指向脂质代谢。
J Cell Mol Med. 2018 Jan;22(1):533-545. doi: 10.1111/jcmm.13341. Epub 2017 Sep 25.
4
Properdin binding to complement activating surfaces depends on initial C3b deposition.备解素与补体激活表面的结合取决于初始C3b沉积。
Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E534-E539. doi: 10.1073/pnas.1612385114. Epub 2017 Jan 9.
5
The role of properdin in zymosan- and Escherichia coli-induced complement activation.甘露聚糖结合凝集素途径中备解素的作用。
J Immunol. 2012 Sep 1;189(5):2606-13. doi: 10.4049/jimmunol.1200269. Epub 2012 Jul 30.
6
Properdin: New roles in pattern recognition and target clearance.备解素：模式识别与靶点清除中的新作用。
Mol Immunol. 2008 Oct;45(16):4048-56. doi: 10.1016/j.molimm.2008.06.034. Epub 2008 Aug 8.
7
The alternative complement pathway revisited.重新审视替代补体途径。
J Cell Mol Med. 2008 Aug;12(4):1074-84. doi: 10.1111/j.1582-4934.2008.00350.x. Epub 2008 Apr 15.
8
Complement deficiency.补体缺陷
Clin Rev Allergy Immunol. 2000 Oct;19(2):83-108. doi: 10.1385/CRIAI:19:2:83.
9
The complement system: its importance in the host response to viral infection.补体系统：其在宿主对病毒感染的应答中的重要性。
Microbiol Rev. 1982 Mar;46(1):71-85. doi: 10.1128/mr.46.1.71-85.1982.
10
Activation of the alternative complement pathway by Trichomonas vaginalis.阴道毛滴虫对替代补体途径的激活。
Infect Immun. 1981 Oct;34(1):268-73. doi: 10.1128/iai.34.1.268-273.1981.
Zotero 插件